This stock we are pitching today is dropping fast for the wrong reasons and now has a P/E of near 5x. This is despite being a growth company with the lowest risk it has had in years. However, we believe the P/E could eventually expand to over 20x, setting us up for a rare multibagger move of at least 300%.
Sometimes the best opportunities in microcap investing aren’t buried in futuristic tech or obscure biotech patents. Sometimes, they’re hiding in plain sight.